Skip to main content

Table 2 Availability (%) of essential medicines and technologies for NCDs at public secondary care facilities

From: Preparedness of primary and secondary health facilities in India to address major noncommunicable diseases: results of a National Noncommunicable Disease Monitoring Survey (NNMS)

Disease Items based on NPCDCS guidelines Community Health Centre District Hospitals
NPCDCSa (n = 281) Others (n = 105) Total
N = 415
NPCDCSa (n = 290) Others (n = 45) Total
N = 335
  Availability (95% CI)  
Diabetes mellitus Medicines - At least one of each - hypoglycemic agent and insulin 55.2 (49.3–60.9) 43.3 (35.1–51.8) 51.3 (46.5–56.1) 74.5 (69.1–79.2) 73.3 (58.6–84.2) 74.3 (69.4–78.7)
Technologies - At least one of each - lancets. Glucometer, biochemical analyser, glucostrips, urine strips reagents/kits for glucose test and for lipid profile, centrifuge 21.7 (17.3–26.9) 13.4 (8.6–20.3) 19.0 (15.5–23.1) 50.3 (44.6–56.1) 51.1 (36.8–65.3) 50.4 (45.1–55.8)
Both medicines & technologies as defined above 17.1 (13.1–22.0) 9.0 (5.1–15.1) 14.5 (11.4–18.2) 42.1 (36.5–47.8) 42.2 (28.8–56.9) 42.1 (36.9–47.5)
Cardio-vascular diseases Medicines - At least one each - ‘anti platelet agent, betablocker, long acting calcium channel blocker, ACE inhibitor, diuretic, nitrate, statin / lipid lowering medicines, medicines for shock and heart failure. 39.9 (34.3–45.7) 21.6 (15.5–29.4) 34.0 (29.6–38.7) 59.0 (53.2–64.5) 62.2 (47.4–75.1) 59.4 (54.0–64.5)
Technologies - At least one of each - B.P. Apparatus, Stethoscope, Measuring Tape, weighing scale, Height scale, Cardiac Monitor, Defibrillator, ECG machine & Roll, 12 Channel stress ECG Tread Mill. 1.1 (0.3–3.3) 2.2 (0.7–6.7) 1.4 (0.6–3.2) 20.3 (16.1–25.4) 11.1 (4.7–24.1) 19.1 (15.2–23.7)
Both medicines & technologies as defined above 1.1 (0.3–3.3) 0.7 (0.1–5.1) 1.0 (0.4–2.5) 16.6 (12.7–21.3) 8.9 (3.4–21.4) 15.5 (12.0–19.8)
Chronic Respiratory Diseases Medicines – At least one of each - Bronchodilator, a steroid inhalant. 19.2 (15.0–24.3) 17.9 (12.3–25.4) 18.8 (15.3–22.9) 36.6 (31.2–42.3) 31.1 (19.3–45.9) 35.8 (30.9–41.1)
Technologies - At least one of each - Nebulizer and Pulse Oximeter. 75.4 (70.1–80.1) 61.9 (53.4–69.8) 71.1 (66.5–75.3) 94.5 (91.2–96.6) 84.4 (70.8–92.4) 93.1 (89.9–95.4)
Both medicines & technologies as defined above 17.4 (13.4–22.3) 15.7 (10.4–22.9) 16.9 (13.6–20.8) 35.2 (29.9–40.9) 31.1 (19.3–45.9) 34.6 (29.7–39.9)
All above NCDs Medicines - Inclusive of above medicines for specific diseases 13.2 (9.7–17.7) 8.2 (4.6–14.2) 11.6 (8.8–15.0) 28.3 (23.4–33.7) 22.2 (12.4–36.6) 27.5 (22.9–32.5)
Technologies - Inclusive of above technologies for specific diseases 0.4 (0.0–2.5) 0.7 (0.1–5.1) 0.5 (0.1–1.9) 14.5 (10.9–19.0) 6.7 (2.2–18.8) 13.4 (10.2–17.5)
Both medicines & technologies as defined above 0.4 (0.0–2.5) 0.7 (0.1–5.1) 0.5 (0.1–1.9) 14.5 (10.9–19.0) 6.7 (2.2–18.8) 13.4 (10.2–17.5)
  1. aFacilities where National Program for Prevention and Control of Cancer, Diabetes and Cardio-vascular Diseases including Stroke has been officially implemented and others are where it has been not officially implemented and status unknown